Bafrekalant 是一种二氮杂双环取代的咪唑并[1,2-a]嘧啶衍生物。Bafrekalant 具有研究呼吸障碍的潜力，包括与睡眠相关的呼吸障碍，如阻塞性和中枢性睡眠呼吸暂停和打鼾 (信息提取自专利 WO2018228907A1)。
货号:ajcx38440
CAS:2256770-44-0
分子式:C29H31ClN6O2
分子量：531.05
溶解度:DMSO : 250 mg/mL (470.77 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).

[1]. Martina Delbeck, et al. Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders. Patent WO2018228907A1.